Page last updated: 2024-08-24

rhodamine 123 and baicalein

rhodamine 123 has been researched along with baicalein in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, JS; Li, C; Shin, SC1
Ma, S; Miao, P; Miao, Q; Wang, Z; Zhang, Y; Zhao, Y1
Bie, B; Duan, B; Guo, Y; Huang, C; Li, J; Li, Z; Sun, J; Yang, J; Yang, S; Zhou, R1

Other Studies

3 other study(ies) available for rhodamine 123 and baicalein

ArticleYear
Effects of baicalein, an antioxidant, on the bioavailability of doxorubicin in rats: possible role of P-glycoprotein inhibition by baicalein.
    Die Pharmazie, 2009, Volume: 64, Issue:9

    Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antioxidants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Doxorubicin; Flavanones; Fluorescent Dyes; Half-Life; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Rhodamine 123

2009
In vitro potential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs.
    Pharmaceutical biology, 2016, Volume: 54, Issue:9

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Caco-2 Cells; Dose-Response Relationship, Drug; Down-Regulation; Flavanones; Flavonoids; Fluorescein; Humans; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Male; Molecular Structure; Permeability; Rats, Sprague-Dawley; Rhodamine 123; Structure-Activity Relationship; Time Factors; Verapamil

2016
Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and Epirubicin by activating apoptosis and ameliorating P-glycoprotein activity.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 98

    Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; bcl-X Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cytoprotection; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Flavanones; Fluorouracil; Hepatocytes; Humans; Liver Neoplasms; Rhodamine 123; Transcription, Genetic

2018